Get Your Personalized Supplement StackSupplement Stack Quiz

Tissue Concentrates

Also known as: Autologous platelet concentrates, Platelet-rich plasma, Platelet-rich fibrin, Tissue-derived concentrates, APCs, PRP, PRF, Autologous Platelet Concentrates

Overview

Tissue concentrates, primarily autologous platelet concentrates (APCs) like platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), are biologically derived products concentrated from a patient's own blood or tissue. These concentrates are rich in platelets, growth factors (such as PDGF, TGF-β, and VEGF), and cytokines, which promote tissue healing and regeneration. They are widely used in regenerative endodontics, orthopedics (e.g., osteoarthritis treatment), sports medicine, and wound healing to stimulate tissue repair and reduce inflammation. APCs are minimally manipulated and intended to enhance natural healing processes. Research maturity is moderate to advanced, with numerous randomized controlled trials (RCTs) and meta-analyses evaluating efficacy in various clinical contexts, particularly in dental and musculoskeletal applications. The quality of available evidence is mixed but increasingly robust, with systematic reviews and meta-analyses providing moderate to high-quality evidence.

Benefits

In regenerative endodontics, APCs significantly improve apical closure, with studies showing a 17% higher likelihood of apical closure compared to traditional blood-clot methods (RR = 1.17, 95% CI: 1.01–1.37). APCs also enhance dentinal wall thickness, root length increase, calcific barrier formation, and vitality response, contributing to improved tooth regeneration. Young patients with immature necrotic permanent teeth benefit significantly from these procedures. In musculoskeletal applications, tissue concentrates like PRP have demonstrated efficacy in improving pain and function in knee osteoarthritis, although effect sizes vary across studies. Patients with knee osteoarthritis may experience symptomatic relief and functional improvement. Benefits in dental regeneration are observed over months post-procedure, while osteoarthritis symptom improvements are typically assessed over weeks to months.

How it works

Tissue concentrates work by releasing growth factors such as PDGF, TGF-β, and VEGF from platelets, which stimulates cellular proliferation, angiogenesis, and extracellular matrix synthesis. This process acts locally at the site of injury or degeneration to promote tissue repair and modulate inflammation. The growth factors interact with specific molecular targets, including platelet-derived growth factor receptors, transforming growth factor-beta receptors, and vascular endothelial growth factor receptors. Administered locally, the bioavailability of these concentrates depends on the concentration and delivery method. The autologous origin minimizes immune reactions, enhancing their effectiveness and safety.

Side effects

Due to their autologous nature, tissue concentrates are generally safe, with a low risk of immune reaction or disease transmission. Common side effects, occurring in more than 5% of cases, include mild localized pain or swelling at the injection site. Uncommon side effects, affecting 1-5% of patients, may include temporary inflammation or bruising. Rare side effects, occurring in less than 1% of cases, involve infection at the injection site, which is rare with proper aseptic technique. No significant systemic drug interactions have been reported. Contraindications include active infections at the injection site, platelet disorders, or severe systemic illnesses. Caution is advised in patients with bleeding disorders or those on anticoagulants.

Dosage

The minimum effective dose varies by application. In endodontics, specific platelet concentration protocols are followed, typically aiming for platelet concentrations 3-5 times baseline in PRP preparations. The maximum safe dose is limited by the volume that can be safely injected locally, with no systemic toxicity reported. Tissue concentrates are administered at the time of surgical or regenerative procedures, and repeat dosing protocols vary. PRP, PRF, and other APCs are prepared via centrifugation protocols standardized for clinical use. Local retention and gradual release of growth factors are critical for efficacy. No specific cofactors are required, as autologous blood components provide the necessary elements.

FAQs

Is tissue concentrate therapy safe?

Yes, autologous tissue concentrates have a strong safety profile due to their autologous nature, which minimizes the risk of adverse immune reactions.

How soon will I see results?

Results vary; dental regeneration effects may take months, while osteoarthritis symptom relief may be noticed within weeks, depending on the individual and the specific application.

Can tissue concentrates be used with other treatments?

Yes, tissue concentrates are often combined with surgical or physical therapies to enhance outcomes, providing a synergistic effect in promoting tissue repair.

Are all tissue concentrates the same?

No, different preparation methods (PRP, PRF) yield varying concentrations and biological activity, affecting their efficacy in different applications.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC7600252/ – This systematic review and meta-analysis of 10 RCTs focused on young patients with immature necrotic permanent teeth. The study found that APCs significantly improved apical closure, dentinal wall thickness, root length, and vitality response, indicating their effectiveness in dental regeneration compared to traditional methods.
https://www.mdpi.com/2079-7737/11/9/1254 – This review discusses the benefits and drawbacks of APCs in hard tissue regeneration across various clinical applications. It supports the clinical use of APCs in promoting tissue repair, highlighting their advantages in enhancing natural healing processes while also acknowledging limitations in certain applications.
https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1556133/full – This Bayesian network meta-analysis of RCTs examined the efficacy of dietary supplements, including tissue concentrates, for knee osteoarthritis. The study found that APCs ranked among the effective interventions for improving pain and function in patients with knee osteoarthritis, suggesting their potential as a therapeutic option.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6769754/ – This article discusses the use of platelet-rich fibrin (PRF) in regenerative endodontics. It highlights PRF's role in promoting angiogenesis and tissue regeneration, making it a valuable tool in enhancing the success of endodontic procedures.
https://bjsm.bmj.com/content/52/6/376 – This study investigates the use of platelet-rich plasma (PRP) for the treatment of knee osteoarthritis. The findings suggest that PRP injections can provide symptomatic relief and improve joint function in patients with mild to moderate knee osteoarthritis.